Patents Assigned to Transition Therapeutics Inc., a Canada corporation
  • Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases
    Publication number: 20040198827
    Abstract: The present invention relates to the use of rhein or diacerhein compounds to treat and prevent vascular diseases that cause obstruction of the vascular system such as blood vessel restenosis and atherosclerosis.
    Type: Application
    Filed: April 27, 2004
    Publication date: October 7, 2004
    Applicant: Transition Therapeutics Inc., a Canada corporation
    Inventors: Tony Cruz, Aleksandra Pastrak